title: How do formulation and process parameters impact blend and unit dose uniformity? Further analysis of the product quality research institute blend uniformity working group industry survey.
abstract: Responses from the second Product Quality Research Institute (PQRI) Blend Uniformity Working Group (BUWG) survey of industry have been reanalyzed to identify potential links between formulation and processing variables and the measured uniformity of blends and unit dosage forms. As expected, the variability of the blend potency and tablet potency data increased with a decrease in the loading of the active pharmaceutical ingredient (API). There was also an inverse relationship between the nominal strength of the unit dose and the blend uniformity data. The data from the PQRI industry survey do not support the commonly held viewpoint that granulation processes are necessary to create and sustain tablet and capsule formulations with a high degree of API uniformity. There was no correlation between the blend or tablet potency variability and the type of process used to manufacture the product. Although it is commonly believed that direct compression processes should be avoided for low API loading formulations because of blend and tablet content uniformity concerns, the data for direct compression processes reported by the respondents to the PQRI survey suggest that such processes are being used routinely to manufacture solid dosage forms of acceptable quality even when the drug loading is quite low.
authors.affiliation: Pfizer Inc., Groton, Connecticut 06340, USA. bruno.c.hancock@pfizer.com
authors.forename: Bruno C
authors.initials: BC
authors.lastname: Hancock
authors.forename: Salvador
authors.initials: S
authors.lastname: Garcia-Munoz
mesh_terms: D002214:Capsules / Q000737:chemistry; D004339:Drug Compounding / Q000379:methods*; D005079:Excipients / Q000737:chemistry; D004364:Pharmaceutical Preparations / Q000737:chemistry; D011786:Quality Control; D013607:Tablets / Q000737:chemistry
chemical_list: D002214:Capsules; D005079:Excipients; D004364:Pharmaceutical Preparations; D013607:Tablets